清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Comment on “A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction”

医学 还原(数学) 机构 精算学 淋巴系统 普通外科 病理 法学 几何学 数学 政治学 业务
作者
Wei Liu
出处
期刊:Journal of Surgical Oncology [Wiley]
标识
DOI:10.1002/jso.28092
摘要

We read with great interest the article by Huang et al. titled "A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction" published in the Journal of Surgical Oncology [1]. The authors provide valuable insights into the disparities in access to immediate lymphatic reconstruction (ILR) and its impact on breast cancer-related lymphedema (BCRL) outcomes. While the study highlights important issues related to insurance coverage and socioeconomic barriers, we would like to offer several suggestions to further strengthen the findings and provide additional context for future research. The study effectively demonstrates that insurance coverage significantly impacts access to ILR, particularly for patients with Medicaid or lower socioeconomic status. However, the discussion could be expanded to include a broader analysis of how insurance policies vary across different states and insurers. For instance, a 2022 study by Finkelstein et al. found that nearly half of insurers in the United States lack publicly available policies on lymphedema treatments, leading to inconsistent coverage and reimbursement for procedures like ILR [2]. This study could be referenced to emphasize the systemic nature of the problem and the need for standardized insurance policies. The authors briefly mention the lack of Current Procedural Terminology (CPT) codes for ILR as a barrier to insurance coverage. This is a critical issue that warrants further discussion. The absence of specific CPT codes for ILR makes it easier for insurers to deny coverage, as the procedure is not formally recognized in billing systems. A 2021 study by Johnson et al. highlighted the challenges of obtaining reimbursement for ILR due to the lack of standardized coding, which limits its widespread adoption [3]. We recommend that the authors advocate for the development of specific CPT codes for ILR to improve access and reimbursement. The study briefly touches on the financial constraints faced by patients, but it could benefit from a more detailed discussion of the long-term economic burden of BCRL. A 2019 study by Dean et al. found that breast cancer survivors with lymphedema face up to 112% higher out-of-pocket costs compared to those without lymphedema, leading to reduced access to care and delayed retirement [4]. Including this data would strengthen the argument for ILR as a cost-effective preventive measure that could reduce long-term healthcare expenditures. The study identifies racial and socioeconomic disparities in access to ILR, but it could further explore the underlying factors contributing to these disparities. For example, a 2022 study by Montagna et al. found that Black and Hispanic patients are at significantly higher risk of developing BCRL after axillary lymph node dissection (ALND) and radiation therapy, independent of other risk factors [5]. This suggests that structural barriers, such as access to preventive care and insurance coverage, disproportionately affect minority populations. Including this evidence would underscore the need for targeted interventions to address these disparities. The authors acknowledge the limitations of their study, including its single-center design and qualitative assessment of lymphedema. We recommend that future research include multicenter studies with standardized diagnostic criteria for lymphedema, such as limb volume measurements or bioimpedance spectroscopy, to provide more objective data. Additionally, longitudinal studies with longer follow-up periods are needed to assess the durability of ILR in preventing BCRL. A 2019 meta-analysis by Johnson et al. found that ILR significantly reduces the risk of BCRL, but longer-term data are still lacking [6]. In conclusion, Huang et al. have provided a valuable contribution to the literature on ILR and its role in preventing BCRL. By addressing the issues of insurance coverage, socioeconomic disparities, and the need for standardized coding, this study highlights the importance of improving access to preventive surgical interventions. We believe that incorporating the additional evidence and recommendations outlined above will further strengthen the study's impact and provide a more comprehensive understanding of the barriers to ILR. The author has nothing to report. Wei Liu drafted and reviewed the article. The author declares no conflicts of interest. The author has nothing to report.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
单纯的忆安完成签到 ,获得积分10
2秒前
zhexin_Lv完成签到 ,获得积分10
9秒前
畅快的夜云完成签到,获得积分10
11秒前
一天完成签到 ,获得积分10
22秒前
优秀笑柳完成签到,获得积分10
33秒前
无奈奎完成签到,获得积分10
36秒前
闫小昊完成签到,获得积分10
38秒前
先锋完成签到 ,获得积分0
45秒前
smile完成签到 ,获得积分10
45秒前
huminjie完成签到 ,获得积分10
46秒前
小米_M完成签到 ,获得积分10
46秒前
黑质完成签到,获得积分10
54秒前
57秒前
天很蓝完成签到,获得积分10
1分钟前
adeno完成签到,获得积分10
1分钟前
tph完成签到 ,获得积分10
1分钟前
1分钟前
虚幻的雁山完成签到,获得积分10
1分钟前
SAY完成签到 ,获得积分10
1分钟前
piaoaxi完成签到 ,获得积分10
1分钟前
端庄平萱完成签到,获得积分10
1分钟前
Beyond095完成签到 ,获得积分10
1分钟前
瘦瘦的枫叶完成签到 ,获得积分10
1分钟前
2344完成签到 ,获得积分10
1分钟前
曾经不言完成签到 ,获得积分10
1分钟前
加倍努力完成签到 ,获得积分10
1分钟前
独特珩完成签到,获得积分10
1分钟前
昴星引路完成签到 ,获得积分10
1分钟前
1分钟前
空儒完成签到 ,获得积分10
1分钟前
周铖完成签到 ,获得积分10
1分钟前
rum完成签到 ,获得积分10
2分钟前
笛卡尔的情书完成签到 ,获得积分10
2分钟前
2分钟前
任伟超完成签到,获得积分10
2分钟前
隐形雅柔完成签到,获得积分10
2分钟前
久晓完成签到 ,获得积分10
2分钟前
zj完成签到 ,获得积分10
2分钟前
归海一刀完成签到 ,获得积分10
2分钟前
谦让的沛芹完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180034
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808628
捐赠科研通 7776034
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557405
邀请新用户注册赠送积分活动 2478998